Median Effective Dose of Remifentanil for the Prevention of Pain Caused by the Injection of Rocuronium
Clinical trial NCT05217238 · UNKNOWN
Trial details
- NCT number
- NCT05217238
- Sponsor
- Yangzhou University
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-18
- Primary completion
- 2022-03-30
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.